Special Tutorial Programme Professor Deirdre J Murphy Trinity College.

Slides:



Advertisements
Similar presentations
Minimally Invasive Surgery in Gynecologic Oncology
Advertisements

Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
1 Female Reproductive Disorders. 2 Problems Related to Menstruation Premenstrual Syndrome Dysmenorrhea Oligomenorrhea Amenorrhea Menorrhagia Metrorrhagia.
OPTIONAL LOGO HERE Prevalence of endometrial cancer in symptamatic women with thickened endometrium Dr Maheswari SRINIVASAN MRCOG SpR, Mrs Shagaf BAKOUR.
Pelvic Masses & Ovarian Cancer. Differential diagnosis of pelvic masses Investigations and management Benign ovarian cysts Ovarian cancer.
Epidemiology of Gynaecological Cancers. General Overview On global basis cervical cancer is the most common pelvic malignancy in developing countries.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Gynecologic Cancers Presented by: Michael Goodheart, MD Assistant Professor Gynecologic Oncology The University of Iowa Hospitals & Clinics Understanding,
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
Malignant disease of the cervix
Tim Broadhead Consultant Gynaecologist & Gynaecological Oncologist
Gynaecological Cancers
Carcinoma of the Vulva.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
Special Tutorial Programme Professor Deirdre J Murphy Trinity College.
Endometrial Cancer Nancy Wozniak, MD.
District 1 ACOG Medical Student Teaching Module 2009
Female Genital Tract 1-Vulva 2-Vagina 3-Cervix 4-Uterine corpus
Malignant Ovarian Tumors
Post Menopausal Bleeding
CARCINOMA OF THE ENDOMETRIUM
Ovarian cancer….. in 15 minutes
 Cervical cancer is a malignant tumour deriving from cells of the "cervix uteri", which is the lower part of uterus.  Begins in the lining of the cervix.
Ovarian tumours.
Management of Gynaecological Cancers. Gynaecological Cancers in NSW 1180 new cases in % of all new cancer diagnoses Crude incidence rate 35.3 per.
Focus on Ovarian Cancer (Relates to Chapter 54, “Nursing Management: Female Reproductive Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc.,
Reproductive health. Cancer Definition Cancer Definition The abnormal growth of cells without normal control of body. Types of Cancer  Malignant Cancer.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Cancer of the Vulva. Essentials of Diagnosis Typically occurs in postmenopausal women. Long history of vulvar irritation with pruritus, local discomfort,
 The term post menopause is applied to women who have not experienced a menstrual bleed for a minimum of 12 months, assuming that they do still have.
Cervical Cancer. Cervix Lower part of the uterus Lower part of the uterus Connects the body of the uterus to the vagina (birth canal) Connects the body.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.
Endometrial and ovarian cancer. Uterine anatomy and tumor origins Uterine cancer: Endometrium: endometrial carcinoma (type I and II) Myometrium: uterine.
Christopher R. Graber, MD Salina Women’s Clinic 08 March 2011.
Vulvar Cancer A. Gari MD..
Ovarian Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Post-menopausal bleeding PV Dr Nasira Sabiha Dawood.
Ovarian Tumours Max Brinsmead MBBS PhD November 2014.
In the name of God Isfahan medical school Shahnaz Aram MD.
Management of ovarian cysts
Endometrial Carcinoma
TEMPLATE DESIGN © ONCOLOGICAL REFERRAL PATTERNS OF GYNAECOLOGICAL CANCER PATIENTS OVER 2010 – 2011 THE NEED FOR GYNAECOLOGIC.
Adult Medical-Surgical Nursing
Urinary Tract System Bladder Cancer.
In the name of God Cervical Cancer Dr.T allameh MD.
Dr. Saadeh Jaber OBGYN consultant Epidemiology Second most common gynecological cancer. >35, median 70 It accounts for deaths more than cancer of.
‘Let’s get it right - Referral for suspected Cancer’
Ovarian and Endometrial Cancer Using risk factors to help triage Adam Rosenthal PhD MRCOG Consultant Gynaecologist and Gynaecological Oncologist.
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
By Dr. Nadia Saddam AL.Assady C.A.B.O.G. Malignant disease of the uterus: Endomaterial carcinoma (CA) has good prognosis in which (5 years survival rate.
Suspected cancer: recognition and referral NICE guidelines [NG12] Published date: June 2015 also cancer researchuk Dr Jane Wilcock.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Invasive cervical cancer. Background Most common cancer of women in Africa, most common gynaecologic cancer, most common cancer of black and coloured.
KARIMA SALAMA ENDOMETRIAL CANCER. Epidemiology Most common gynecological cancer in the developed countries, with an incidence of 12.9 per 100,000 women.
Adult Medical-Surgical Nursing Reproductive Health Module: Endometrial Cancer.
Mark Browning, M.D. IUSME.  22,000 Cases  14,000 Deaths  Overall Survival Rate is 35%  Survival Rate Depends on Stage.
SCREENING IN GYNECOLOGICAL CANCER Taravat Fakheri OB/GYN KUMS.
Metastatic Tumors of Ovary. METASTATIC TUMOR FROM BREAST CANCER both ovaries replaced by pale, rather nodular tumor, with breast cancer cells arranged.
Early Diagnosis of Gynaecological Cancer Rob Gornall Consultant Gynaecology GHNHST.
M.D. Browning, M.D. ‘77.  Most Common Cancer of Female Reproductive System  60,000/year with 10,000 deaths  Normal Cells in the Endometrium.
Post Menopausal Bleeding
Uterine cancer Uterine mesenchymal neoplasms
Malignant Ovarian Neoplasms
Vulvar Cancer Women’s Hospital,School of Medicine Zhejiang University.
Ovarian Cancer-Route to Diagnosis
ENDOMETRIAL CARCINOMA
Suspected Gynaecological Cancer Recognition & Referral
Presentation transcript:

Special Tutorial Programme Professor Deirdre J Murphy Trinity College

Overview Gynaecological Cancer

Objectives Epidemiology Gynaecological History Gynaecological examination Investigations Management

Patient 1 Age 70 years Lower genital tract itch Slight vaginal discharge

Vulval / Vaginal cancer

Clinical Age > 60 years No specific risk factors 95% squamous Pruritus / bleeding / discharge Ulcer / Mass / Inguinal nodes

Investigations Biopsy Staging – surgical / histological Pre-op work-up

Management Wide local excision Radical vulvectomy Bilat groin lymphadenectomy +/- radiotherapy Prognosis I >90% 5yrIII/IV 40%

Patient 2 Age 47 years Post-coital bleeding No smears

Cervical cancer

Clinical Age peak CIN / Partners / HPV / HIV / Smoker Squamous 90% / Adeno 10%

Clinical PCB / IMB / Discharge / PMB / None Ulcer / mass visible / palpable Late stage – organ symps / mass

Investigations Biopsy Staging – Clinical / Histological Pre-op work-up EUA / Cystoscopy / CT / IVP

Management Ia 1 MicroinvasionCone biopsy I – IIa Surgery / Radiotherapy AdvancedRadiotherapy Prognosis overall 65% 5 year

Patient 3 Age 65 years PMB Tamoxifen

Uterine / Endometrial cancer

Clinical Age >/= 60 years Risk factors: unopposed oestrogen – exogenous / obesity / PCOS / nullip / late menopause / tamoxifen Protective:COCP / HRT combined Adenocarcinoma 85%

Clinical PMB / Irreg menses / IMB Normal examination

Investigations TVS endometrial thickness Endometrial biopsy Staging – surgical / histological / nodes Pre-op work-up CT/MRI

Management Controversial TAH / BSO / Vag cuff / Nodes Radiotherapy [Progestagens] Prognosis Ia >90% 5 year All 65%

Patient 4 Age 70 years Bloating Clothes a bit tight

Ovarian cancer

Clinical Age peak yearsRare young Epithelial – serous / mucinous / clear Germ cell - dermoid Sex-cord stromal Secondary malig Early menarche / late menopause / nullip / ovul induction / familial 4%

Clinical Silent Abd distension/ Bloating / Dyspepsia Mass effects Mass / Ascites / Cachexia / Breasts

Investigations Ultrasound scan Ca 125 Pre-op work-up Laparotomy - Staging

Management Debulking surgery Chemotherapy – cisplatin / taxol Paracentesis Prognosis 25% 5 yearIII 15% IV 5% Palliative care

Course evaluation

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.